Carregant...
Molecular Targeted Therapies in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a complex and heterogeneous tumor with several genomic alterations. There is evidence of aberrant activation of several signaling cascades such as EGFR, Ras/ERK, PI3K/MTOR, HGF/MET, Wnt, Hedgehog and apoptotic signaling, Recently a multikinase inhibitor, sorafenib,...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2597642/ https://ncbi.nlm.nih.gov/pubmed/18821591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.22506 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|